Skip to main content

Table 3 Overview of pharmaceutical companies contributing to IMI

From: Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making?

  Total number of teams active in IMI projects
Sanofi 51
GlaxoSmithKline 47
Johnson & Johnson 46
AstraZeneca 44
Novartis 36
Pfizer 34
Eli Lilly 32
Roche 31
Bayer 29
Boehringer Ingelheim 28
UCB 25
Novo Nordisk 21
Merck 20
Amgen 16
AbbVie 13
Merck & Co. 10
Takeda 7
BristolMyersSquibb 5
  1. Source: http://www.imi.europa.eu/projects-results/project-factsheets